Neil Martinson to Rifampin
This is a "connection" page, showing publications Neil Martinson has written about Rifampin.
Connection Strength
2,188
-
Occult rifampicin-resistant tuberculosis: better assays are needed. Lancet Infect Dis. 2018 12; 18(12):1293-1295.
Score: 0,564
-
New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med. 2011 Jul 07; 365(1):11-20.
Score: 0,340
-
Pregnancy in Women With HIV in a Tuberculosis Preventive Therapy Trial. J Acquir Immune Defic Syndr. 2022 12 01; 91(4):397-402.
Score: 0,188
-
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial. Ann Intern Med. 2021 10; 174(10):1367-1376.
Score: 0,172
-
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718.
Score: 0,168
-
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial. Ann Intern Med. 2017 11 21; 167(10):689-697.
Score: 0,132
-
Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants. J Antimicrob Chemother. 2017 07 01; 72(7):2028-2034.
Score: 0,129
-
Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure. J Clin Microbiol. 2016 12; 54(12):3028-3033.
Score: 0,123
-
Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa. Antimicrob Agents Chemother. 2015 Dec 07; 60(3):1234-41.
Score: 0,116
-
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis. Lancet Respir Med. 2023 09; 11(9):782-790.
Score: 0,048
-
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study). Am J Respir Crit Care Med. 2022 May 15; 205(10):1214-1227.
Score: 0,045
-
Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. Lancet Infect Dis. 2022 04; 22(4):507-518.
Score: 0,044
-
Challenges in recruiting children to a multidrug-resistant TB prevention trial. Int J Tuberc Lung Dis. 2021 10 01; 25(10):814-822.
Score: 0,043
-
Evolving therapies for rifampicin-resistant tuberculosis: balancing efficacy and toxicity. Lancet Respir Med. 2020 04; 8(4):326-328.
Score: 0,039
-
Sputum culture and drug sensitivity testing outcome among X-pert Mycobacterium tuberculosis/rifampicin-positive, rifampicin-resistant sputum: A retrospective study - Not all rifampicin resistance is multi-drug resistant. J Glob Antimicrob Resist. 2020 06; 21:434-438.
Score: 0,038